Serum Ferritin Compared with Other Indices of Iron Status in

Children and Teenagers UndergoingMaintenance Hemodialysis Demetrius Ellis
To determine how best to assess iron status, I studied 12 young renal patients (ages 5.5 to 20 years) undergoing regular hemodialysis treatments. Iron balance was estimated by monitoring iron loss ascribable to blood loss during dialysis and diagnostic testing, and iron intake in the form of oral and intravenous iron supplements and blood transfusions. Traditional methods of evaluating iron status-measurement of hemoglobin, erythrocyte indices, reticulocyte count, iron, and transferrin-were Compared with measurement of serum ferritin. The serum ferritin measurements provided superior information. In three cases this method was superior to visual assessment of bone marrow stained for iron. 
iron overload monitoring results of therapy
Normocytic normochromic anemia is a well-known consequence of chronic renal failure. Etiologic possibilities include one or a combination of the following factors: diminished erythropoietic-stimulating factor resulting from renal parenchymal damage (1) , removal of folate and other watersoluble vitamins during dialysis (2) , shortened erythrocyte survival in uremic patients (3) , blood loss related to the dialysis process and frequent blood studies (4, 5) , occult blood loss (6) , dietary deficiency of iron, protein-calorie malnutrition, surgical procedures, infection, and hypersplenism.
In addition to adequate dialysis, supplementation with vitamins and iron is believed to be beneficial in treating this anemia, especially in the patient who is not transfused (7, 8 
Materials and Methods
Subjects
Twelve young persons (seven girls, five boys) with end-stage renal failure were studied. They received two to three dialysis treatments per week, each lasting 4 to 5 h. All dialyses were performed during the hours 0800 to 1400. 
Procedures
To estimate the amount of blood trapped in the dialyzer and connecting lines, I rinsed the entire assembly with 200 mL of a 0.9 mol/L solution of NaCl, then rinsed it with air, dismantled the dialyzer, washed the dialysis membranes, and measured the hematocrit of the eluate. I computed the iron content of blood lost or blood received according to the following relationships: 
Results
Hematologic Data
The mean hemoglobin concentration of the group was 61 g/L with a range of 43 to 88 g/L, and the mean proportion of reticulocytes was 1.8%, with a range of 0. 
Estimation of Iron Balance1
Oral iron intake from dietary iron and iron preparations was estimated for each patient and adjusted by using a minimal absorption factor of 0.13 (14) . tests is also shown ( Table 1 ).
The amount of blood remaining in the dialyzer and connecting lines after the blood was returned to the patient averaged 5 mL (range, 2-10 mL, depending on the size of the dialyzer and the type of blood line used); this accounted for a mean estimated iron loss of 1.97 mg per dialysis, or 0.76 ± 0.18 mg/day when blood losses from diagnostic studies were also considered. 
In Vitro Assessment of Iron Status
Effect of Dialysis on Iron Studies
To avoid artifactual changesin concentrations, that could result from changes in blood volume produced by ultrafiltration during dialysis, the change in body weight and serum albumin concentration was measured before and after dialysis in 10 patients.
Paired t -test analysis of the data showed no significant change in pre-and postdialysis body weight or in concentrations of serum albumin, transferrin, or ferritin. However, the serum iron concentration was significantly increased (p <0.05) after dialysis in nine of these 10 patients, as assessed by chi-square analysis. The mean increase in serum iron concentration was 27%; there was no direct correlation between the concentration of serum iron before dialysis and the percentage increase in serum iron during dialysis.
Discussion
Before introduction of a quantitative assay for serum ferritin, bone-marrow staining for iron was the only clinically available method for direct assessment of iron stores. Because bone-marrow biopsy is an invasive, painful, and relatively inconvenient procedure, it is unsuitable for sequential evaluation of iron stores, particularly in uremic patients. Moreover, there is considerable disagreement as to the age at which bone-marrow staining for iron becomes a reliable indicator of body iron stores (15, 16) 
